ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: IMRIS Inc. (IMRS) Report Updated: Apr 14, 2014 | Print This Page

Get more stock ratings by Louis Navellier

IMRIS Inc. (IMRS)

Rating: Strong Sell Volatility: Aggressive
Total Grade: F Industry: Health Care Equipment & Supplies
Competitors: ATRI, ANIK, LMAT, DHRM

Stock Analysis

Rating: Monthly View

A
B
C
D
F
April May June July August September October November December January February March

Rating: Weekly View

This Week: F down no change
Last Week: F same downgrade
Two Weeks Ago: D up no change
service keys

IMRIS Inc.© quotemedia

Company Profile

IMRIS Inc. provides integrated image guided therapy solutions that deliver information to clinicians during surgical or interventional procedures in Canada, the United States, Europe, the Asia Pacific, and the Middle East. The company designs, manufactures, and markets VISIUS Surgical Theatre, a multifunctional surgical environment that incorporates magnetic resonance (MR) imaging, CT imaging, fluoroscopy, computed tomography, and x-ray angiography into multi-purpose surgical suites to provide intra-operative imaging for medical applications. It also provides ancillary products and services. The company’s solutions serve the neurosurgical, cerebrovascular, and cardiovascular markets worldwide. IMRIS Inc. is based in Winnipeg, Canada.

Recent News: IMRIS Inc.